Home Beauty Health Pfizer's Grip on Paxlovid Thwarts Research on Covid Treatment: Pfizer Inc. is resisting requests for study supplies of its Covid-19 pill, Paxlovid, disappointing researchers who say combining the $22 billion therapy with other drugs might stave off resistance.

on May 18, 2022
Pfizer's Grip on Paxlovid Thwarts Research on Covid Treatment: Pfizer Inc. is resisting requests for study supplies of its Covid-19 pill, Paxlovid, disappointing researchers who say combining the $22 billion therapy with other drugs might stave off resistance. submitted by /u/shallah
[link] [comments]


from Health https://ift.tt/XZw9E4u
,
Share To:

Unknown

View Profile

Post A Comment:

0 comments so far,add yours

Subscribe to: Post Comments (Atom)